Anti-NMDA receptor encephalitis medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Anti-NMDA receptor encephalitis}} {{CMG}} ==Overview== ==Medical Therapy== ==References== {{Reflist|2}} Category:Needs content Category:Rheumatology C..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anti-NMDA receptor encephalitis}} | {{Anti-NMDA receptor encephalitis}} | ||
{{CMG}} | {{CMG}} AE {{DMakkar}} | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
The treatment of anti-NMDAR encephalitis should include immunotherapy and the diagnosis and excision of the tumor. There is evidence that early immunotherapy may result in quicker recovery and decreased mortality. | |||
Current immunotherapy includes corticosteroids, immune plasmapheresis, intravenous immunoglobulins, and rituximab. | |||
==References== | ==References== | ||
Revision as of 11:27, 11 February 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis medical therapy |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]
Overview
Medical Therapy
The treatment of anti-NMDAR encephalitis should include immunotherapy and the diagnosis and excision of the tumor. There is evidence that early immunotherapy may result in quicker recovery and decreased mortality.
Current immunotherapy includes corticosteroids, immune plasmapheresis, intravenous immunoglobulins, and rituximab.